Enzyme Companies in BioPortfolio's Corporate Database
Enzyme company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Enzyme companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Enzyme Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Enzyme Companies.
More Information about Enzyme on BioPortfolio
We have published hundreds of Enzyme news stories on BioPortfolio along with dozens of Enzyme Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Enzyme for you to read.
Showing "enzymes enzyme" Companies 1 to 25 of 253
BuckPower Deer Velvet is imported from New Zealand and marketed by TCCD International, a South Florida manufacturer of natural products. Specially formulated with enzymes, 100% natural BuckPower offers superior absorption over standard deer antler velvet capsules. BuckPower is available at GNC, Vitamin Shoppe, online and other fine retailers nationwide. Fo...
Precision BioSciencesâ mission is to continually provide, improve, and enable the worldâs most powerful genome engineering technology. Precisionâs proprietary Directed Nuclease EditorTM (DNE) technology enables the production of genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or plant ce...
Nanodisc, Inc. owns an exclusive, world-wide commercial license to all applications of Nanodiscs™ – nano scale, discoidal structures composed of specially engineered proteins and phospholipid bilayers. “Nanodiscs™ were discovered and developed by Dr. Sligar, Company Co-Founder, Professor at University of Illinois at Urbana Champaign and a principal investigator in the fede...
CytomX Therapeutics is an early stage biotechnology company developing Probodiesâ¢, or proteolytically-activated antibodies. Probodies combine the well-established power and specificity of monoclonal antibodies with a second level of tissue selectivity, driven by the action of endogenous disease enzymes. Probodies, by their ability to site-direct the activity...
Ansaris is a division of Locus Pharmaceuticals, a privately held biopharmaceutical company focused on solving todayâs small molecule drug discovery challenges, has been the leader in fragment based drug design (FBDD) since its inception in 1999. Ansarisâ proprietary technology platform combines a torsion-space algorithm for building better protein...
NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.
Permeon Biologics is pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Leveraging its novel Intraphilin⢠Technology Platform, which has been exclusively licensed from Harvard University, the companyâs next-generation approach is being developed to unlock the full therapeutic...
Celsis Rapid Detection is the world leader in rapid microbial methods. Utilizing patented enzyme technology, it develops and supplies screening systems (instruments, software, reagents and services) for the rapid detection of microbial contamination in pharmaceutical and consumer products. Its rapid screening systems provide significant economic value by r...
Maine Standards Company, LLC, is located in Windham, Maine. Maine Standards Company manufactures VALIDATE® test kits for over 80 analytes, including general chemistries, urine chemistries, enzymes, lipids, therapeutic drugs, cardiac markers, thyroids and serum proteins. Maine Standards Companyâs goal is to help clinical laboratories easily validate...
Mountain View Pharmaceuticals, Inc.
MVP is a privately-held California corporation with expertise in the application of advanced polymer-coupling technology to make protein-based drugs safer and longer acting. To date, MVP has been granted 168 patents in 48 countries and regions. Of these patents, 105 are co-assigned to Duke University and are licensed to Savient Pharmaceuticals, Inc. for th...
Genkyotex is developing first in class, small molecule therapeutics that specifically and selectively inhibit the NOX family of enzymes. Using a unique screening platform, Genkyotex has identified novel NOX inhibitors with the potential to treat disease areas with a high clinical need and large market potential. Genkyotex was founded in 2006 by scientists...
Orabrush Inc. (www.orabrush.com) is an e-commerce distribution platform that leverages social media marketing, with expertise in YouTube advertising, to commercialize innovative products. Using its âreverse marketing modelâ with YouTube, the company has delivered unprecedented results in awareness and conversion driving online to offline sa...
Orabrush, Inc. (www.orabrush.com) is an e-commerce distribution platform that leverages social media marketing, with expertise in YouTube advertising, to commercialize innovative products. Using its âreverse marketing modelâ with YouTube, the company has delivered unprecedented results in awareness and conversion driving online to offline s...
Dicerna Pharmaceuticals is a private, venture-backed RNAi-focused biopharmaceutical company developing novel therapeutic agents and related drug delivery systems in multiple disease areas based on its proprietary Dicer Substrate Technology⢠platform and Dicer Substrate siRNA (DsiRNA) molecules. Dicer Substrate Technology is a second generation RNAi ap...
Precision's mission is to utilize its engineered endonuclease technology to become the world leader in the field of genomic molecular biology. Precisionâs proprietary Directed Nuclease EditorTM (DNE) technology enables the production of custom genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or pla...
NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds that are in late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosph...
EnzymeRx, LLC is a private, clinical stage biotechnology company developing enzyme-based therapeutics. Our lead product pegsitacase is in phase 1 clinical studies and being developed for the treatment of refractory gout, treatment and prophylaxis of tumor lysis syndrome, and other indications, and we are actively building our preclinical pipeline. For more...
Florida-based Enzymedica, Inc., was founded in 1998 to offer consumers targeted enzyme products. Considered Americaâs #1 selling enzyme brand sold by health food store retailers, Enzymedica's products are made from only the highest quality plant and plant-based enzymes.
Founded in 2000, DiscoveRx is a privately held, venture-backed company headquartered in Fremont, California, with additional offices in San Diego, California and Birmingham, England. The Company pioneered the use of β-galactosidase enzyme fragment complementation in biochemical and cell based assays for discovery research in fields of receptor biology,...
Intrexon Corporation is a privately held life sciences company that employs modular DNA control systems to enhance capabilities, improve safety and lower cost in human therapeutics, protein production, industrial enzymes and ag/bio. The company's advanced transgene engineering platform enables a new level of biotech - combining breakthroughs in DNA control...
Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases and additional en...
Kapa Biosystems is a next-generation life science reagents supplier that employs high-throughput molecular evolution to optimize enzymes for DNA amplification, next-generation DNA sequencing and molecular diagnostic applications. Kapa Biosystems offers a range of next-generation PCR reagents that are fundamentally different at the protein level and designe...
Neurogen Corporation & Ligand Pharmaceuticals
Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory diseases, anemia, asthma, rheumatoid arthritis and psoriasis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based assays, gene-expression t...
Protalix Biotherapeutics, Inc.
Protalix is a biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary plant cell based expression system. Protalixâs ProCellEx(TM) presents a proprietary method for the expression of recombinant proteins that Protalix believes will allow for the cost-e...
